IPASA

We’re proud to announce the new IPASA Executive Committee! Congratulations to Rhulani Nhlaniki, our newly appointed President, and Wendy Cupido, our Vice President for a second term, along with the exceptional team joining them. “It is an exciting moment for our association as we welcome our new executive committee members. Their expertise and leadership will be invaluable in driving our mission forward. I would also like to extend heartfelt thanks to the outgoing executive committee for their remarkable dedication over the past two years. As we embark on this new chapter, our commitment to ensuring patients have access to innovative therapies remains at the heart of everything we do. We are confident that the incoming leadership will continue to champion this mission and lead us to even greater achievements,” says Bada Pharasi. #IPASA #ExCoMembers #Innovation Rhulani Nhlaniki Wendy Cupido Ahmed Rami Barnaby McKay Sara Norcross Jorge Levinson Ahmed S. El Hofy Siphiwe Ledingwane Bada Pharasi

Why is ethical collaboration so important to the future of South Africa's health system? IPASA is thrilled to join alongside more than 25 leading entities to answer this and related questions. In so doing, these diverse stakeholders that span patient organizations, healthcare professional societies, industry bodies, and many others will explore the future potential of a South African Consensus Framework. Such a Framework would serve as a standing platform for ethical collaboration across the health ecosystem and enable South Africa to join alongside 14 countries who have already adopted this approach. Stay tuned for more details and thank you to IFPMA for joining us in this important journey and lending your leadership. #EthicsInHealthcare #BusinessIntegrity #IPASA #SAHPRA #LeadingWithIntegrity

🚨 Tackling Counterfeit Medicines: A Growing Patient Safety Concern in South Africa This World Diabetes Day, we’re highlighting the urgent need for safe and equitable access to diabetes care. At IPASA, we are dedicated to breaking barriers to promote access to innovative medicines for all. However, the growing threat of counterfeit medicines, particularly Glucagon-like Peptide (GLP-1) products, jeopardise patient safety and undermines progress in diabetes care. These counterfeit GLP-1 products, often sold online without SAHPRA’s approval, are untested and frequently misused for cosmetic purposes. The risks are significant, affecting both diabetes patients and those unknowingly using unsafe products. 💡 Tune into Channel Africa as our CEO Bada Pharasi will address this critical issue on how we’re working to combat counterfeit medicines and promote responsible access to quality diabetes treatments. Don’t miss this important conversation on safeguarding patient health! #WorldDiabetesDay #PatientSafety #IPASA #DiabetesCare #SayNotoUntestedMedicine #PatientSafety #SAHPRA

📢 TB campaign awareness continues Catch Bada Pharasi live on SABC today for another in-depth discussion on “Unleashing Innovation Against TB and Strategies Needed for Drug-Resistant TB.” Don’t miss out on this powerful conversation as we dive into the groundbreaking approaches tackling drug-resistant TB. #IPASA #BadaPharasi #Innovation #TB

Tune In Today! 📢 Join us live on the eNCA Today Show at 15:30 as our CEO, Bada Pharasi discusses “Unleashing Innovation Against TB and Strategies Needed for Drug-Resistant TB.” Discover the latest insights on how innovation is crucial in the fight against drug-resistant TB and what strategies are needed to tackle this global health challenge. Don’t miss it! #IPASA #BadaPharasi

Thank you, Zwelethu Bashman, for the dedication and commitment you’ve shown over the past two years as our President. Through your leadership, you have continually pushed all of us to work even harder, always reminding us of our purpose: advocating for patient access to innovative therapies. We are grateful for the impactful initiatives you have guided us through and the strong foundation you have established for the future. We look forward to continuing our collaboration and advancing IPASA’s mission together!

We are honored to have had Deputy Minister Zuko Godlimpi of the Department of Trade, Industry, and Competition join us virtually to deliver the keynote address at the IPASA Annual General Meeting. His insights on trade and industry provided invaluable perspectives as we align on the future of healthcare and pharmaceutical innovation. A heartfelt thank you to all of our CEOs from member companies who continue to walk this journey with us. Your dedication, commitment, and unwavering support are essential as we work to expand patient access to innovative medicines. Together, we look forward to a bright future! #IPASA #AGM #NewLeadership

The 2024 Working Groups shared their priorities for the year ahead. Key insights were presented from Intellectual Property, SAHPRA, National Health Insurance, Working Group, Patient Access to Innovation The session sparked dynamic discussions and valuable engagement, setting the stage for impactful initiatives in 2025. #IPASA #AGM

Today, we gather for the IPASA Annual General Meeting, a pivotal event where we reflect on our achievements and set the course for the year ahead. Our Chairperson, Zwelethu Bashman, kicks off the meeting by welcoming all attendees and setting the tone for an insightful and productive session. #IPASA #AGM #HealthInnovation

Incase you missed this morning's interview of our CEO, Bada Pharasi on Cape Talk, we have got you covered! 😉 Listen to the full audio interview here: https://lnkd.in/dX-f5Zq2